Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

KINDLY MD, INC. (NAKA)

  • Business News
  • May 28, 2026, 23:59 UTC
  • 3
  • 1 comments

Nakamoto Chairman and CEO David Bailey Purchases Additional Shares of Common Stock

Market reaction Comment Full text

MISSION PRODUCE, INC. (AVO)

  • Business News
  • May 28, 2026, 23:47 UTC
  • 2
  • 1 comments

Mission Produce® Completes Acquisition of Calavo Growers, Advancing its North American Avocado & Fresh Produce Platform

Market reaction Comment Full text

SLB LIMITED/NV (SLB)

  • Business News
  • May 28, 2026, 23:38 UTC
  • 2
  • 1 comments

SLB与Vår Energi扩大数字化合作,规模化推进油井与综合油田开发规划

Market reaction Comment Full text

Charlottes Web Holdings Inc. (CWBHF)

  • Business News
  • May 28, 2026, 23:33 UTC
  • 4
  • 1 comments

Charlotte's Web Announces Closing of Transaction with British American Tobacco, Including US$10 Million Investment

Market reaction Comment Full text

SALESFORCE, INC. (CRM)

  • Business News
  • May 28, 2026, 23:31 UTC
  • 4
  • 1 comments

Salesforce Announces Quarterly Dividend

Market reaction Comment Full text

DOUGLAS EMMETT INC (DEI)

  • Business News
  • May 28, 2026, 23:24 UTC
  • 4
  • 1 comments

Douglas Emmett Declares Quarterly Cash Dividend

Market reaction Comment Full text

SLB LIMITED/NV (SLB)

  • Business News
  • May 28, 2026, 23:15 UTC
  • 4
  • 1 comments

SLB e Vår Energi expandem cooperação digital para ampliar o planejamento integrado de desenvolvimento de poços e campos

Market reaction Comment Full text

Johnson & Johnson (JNJ)

  • Business News
  • May 28, 2026, 23:11 UTC
  • 4
  • 1 comments

Johnson & Johnson - FDA approves label expansion, cementingTREMFYA® as the only IL‑23 inhibitor proven to help stop further joint damage

Market reaction Comment Full text

MICROCHIP TECHNOLOGY INC (MCHP)

  • Business News
  • May 28, 2026, 23:11 UTC
  • 3
  • 1 comments

Essential Performance and Real-time Control Without the Baggage

Market reaction Comment Full text

Johnson & Johnson (JNJ)

  • Business News
  • May 28, 2026, 23:10 UTC
  • 4
  • 1 comments

FDA approves label expansion, cementing TREMFYA® as the only IL‑23 inhibitor proven to help stop further joint damage

Market reaction Comment Full text
  • Previous
  • 1714
  • 1715
  • 1716
  • 1717
  • 1718
  • Next

Search

News categories

  • Technical Exchange News(13517)
  • Event(6229)
  • SEC News(351097)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(192849)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin